![Innovent Biologics, Inc. logo](/logos/1801.HK.webp)
Innovent Biologics, Inc.
HKEX:1801.HK
Overview | Financials
Company Name | Innovent Biologics, Inc. |
Symbol | 1801.HK |
Currency | HKD |
Price | 43.15 |
Market Cap | 70,303,432,000 |
Dividend Yield | 0% |
52-week-range | 28.3 - 49.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. De-Chao Yu Ph.D. |
Website | https://www.innoventbio.com |
An error occurred while fetching data.
About Innovent Biologics, Inc.
Innovent Biologics, Inc. operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases. Its principal drug candidate is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody for the treatment of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD